Photodynamic therapy in macular diseases of Asian populations: When east meets west

Japanese Journal of Ophthalmology

Volumn 50, Issue 2, 2006, Pages 161-169

  Chan, Wai Man ^a,b   Lai, Timothy Y Y ^a   Tano, Yasuo ^c   Liu, David T L ^b   Li, Kenneth K W ^a   Lam, Dennis S C ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Asian population; Central serous chorioretinopathy; Choroidal neovascularization; Photodynamic therapy; Polypoidal choroidal vasculopathy

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT;

ASIA; ASIAN; CAUCASIAN; CENTRAL SEROUS RETINOPATHY; CHOROID DISEASE; CLINICAL TRIAL; DRUG SAFETY; ETHNOLOGY; HUMAN; INTERMETHOD COMPARISON; IRRADIATION; LANGUAGE; LASER COAGULATION; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; MYOPIA; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; PUBLICATION; RACE DIFFERENCE; RADIATION DOSE; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; REVIEW; SUBRETINAL NEOVASCULARIZATION; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR DISEASE; VISUAL ACUITY; VISUAL DISORDER; VISUAL IMPAIRMENT;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MACULA LUTEA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RETINAL DISEASES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33645704085     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-005-0259-z     Document Type: Review

References (71)

1. NM Bressler Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group 2001 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of two randomized clinical trials-TAP report 2 Arch Ophthalmol 119 198 207
2. Verteporfin in Photodynamic Therapy Study Group 2001 Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP report No. 1 Ophthalmology 108 841 852
3. Verteporfin in Photodynamic Therapy Study Group 2001 Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy. Report 2 Am J Ophthalmol 131 541 560
4. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group 1999 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of two randomized clinical trials-TAP Report 1 Arch Ophthalmol 117 1329 1345
5. LA Yannuzzi JS Slakter NE Gross 2003 Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study Retina 23 288 298
6. WM Chan DS Lam TY Lai BS Tam DT Liu CK Chan 2003 Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level Br J Ophthalmol 87 1453 1458
7. RF Spaide I Donsoff DL Lam 2002 Treatment of polypoidal choroidal vasculopathy with photodynamic therapy Retina 22 529 535
8. WM Chan DS Lam TY Lai 2004 Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year result of a prospective case series Ophthalmology 111 1576 1584
9. M Uyama M Wada Y Nagai 2002 Polypoidal choroidal vasculopathy: natural history Am J Ophthalmol 133 639 648
10. AK Kwok TY Lai CW Chan 2002 Polypoidal choroidal vasculopathy in Chinese patients Br J Ophthalmol 86 892 897
11. M Uyama K Takahashi N Ida M Miyashiro 2000 The second eye of Japanese patients with unilateral exudative age-related macular degeneration Br J Ophthalmol 84 1018 1023
12. JI Lim A Kwok DK Wilson 1998 Symptomatic age-related macular degeneration in Asian patients Retina 18 435 438
13. K Sho K Takahashi H Yamada 2003 Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics Arch Ophthalmol 121 1392 1396
14. D Husain JW Miller N Michaud E Connolly TJ Flotte ES Gragoudas 1996 Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization Arch Ophthalmol 114 978 985
15. JW Miller U Schmidt-Erfurth M Sickenberg 1999 Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study Arch Ophthalmol 117 1161 1173
16. MF Shuler JL Borrillo AC Ho 2001 Photodynamic therapy update Curr Opin Ophthalmol 12 202 206
17. U Schmidt-Erfurth T Hasan 2000 Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration Surv Ophthalmol 45 195 214
18. RW Flower 1999 Expanded hypothesis on the mechanism of photodynamic therapy action on choroidal neovascularization Retina 19 365 369
19. AM Richter S Cerruti-Sola ED Sternberg D Dolphin JG Levy 1990 Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer in normal and tumor-bearing mice J Photochem Photobiol B 5 231 244
20. JC Maziere P Morliere R Santus 1991 The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours J Photochem Photobiol B 8 351 360
21. VH Fingar 1996 Vascular effects of photodynamic therapy J Clin Laser Med Surg 14 323 328
22. DJ Granville BM [tmp] McManus DW Hunt 2001 Photodynamic therapy: shedding light on the biochemical pathways regulating porphyrin-mediated cell death Histol Histopathol 16 309 317
23. U Schlotzer-Schrehardt A Viestenz GO Naumann H Laqua S Michels U Schmidt-Erfurth 2002 Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes Graefes Arch Clin Exp Ophthalmol 240 748 757
24. U Schmidt-Erfurth H Laqua U Schlotzer-Schrehardt A Viestenz GO Naumann 2002 Histopathological changes following photodynamic therapy in human eyes Arch Ophthalmol 120 835 844
25. M Uyama 1991 Choroidal neovascularization, experimental and clinical study Nippon Ganka Gakkai Zasshi (Acta Soc Ophthalmol Jpn) 95 1145 1180
26. M Yuzawa K Hagita T Egawa H Minato M Matsui 1991 Macular lesions predisposing to senile disciform macular degeneration Jpn J Ophthalmol 35 87 95
27. Japanese Age-Related Macular Degeneration Trial (JAT) Study Group 2003 Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration Am J Ophthalmol 136 1049 1061
28. K Ohno-Matsui T Yoshida 2004 Myopic choroidal neovascularization: natural course and treatment Curr Opin Ophthalmol 15 197 202
29. T Yoshida K Ohno-Matsui K Yasuzumi 2003 Myopic choroidal neovascularization: a 10-year follow-up Ophthalmology 110 1297 1305
30. Y Tano 2002 Pathologic myopia: where are we now? Am J Ophthalmol 134 645 660
31. RD Sperduto D Seigel J Roberts M Rowland 1983 Prevalence of myopia in the United States Arch Ophthalmol 101 405 407
32. TY Wong PJ Foster J Hee 2000 Prevalence and risk factors for refractive errors in adult Chinese in Singapore Invest Ophthalmol Vis Sci 41 2486 2494
33. HE Grossniklaus WR Green 1992 Pathologic findings in pathologic myopia Retina 12 127 133
34. KJ Blinder MS Blumenkranz NM Bressler 2003 Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP. Report no. 3 Ophthalmology 110 667 673
35. DS Lam WM Chan DT Liu DS Fan WW Lai KK Chong 2004 Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization of pathologic myopia in Chinese eyes-a prospective series of one- and two-years follow-up Br J Ophthalmol 88 1315 1319
36. M Secretan D Kuhn G Soubrane G Coscas 1997 Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment Eur J Ophthalmol 7 307 316
37. Y Oshima S Harino Y Tano 1998 Scanning laser ophthalmoscope microperimetric assessment in patients with successful laser treatment for juxtafoveal choroidal neovascularization Retina 18 109 117
38. JM Ruiz-Moreno JA Montero 2002 Long-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyes Eur J Ophthalmol 12 117 122
39. DP Joseph A Uemura MA Thomas 2003 Subretinal surgery for juxtafoveal choroidal neovascularization Retina 23 463 468
40. SY Cohen A Bulik L Dubois G Quentel 2003 Photodynamic therapy for juxtafoveal choroidal neovascularization in myopic eyes Am J Ophthalmol 136 371 374
41. DS Lam DT Liu DS Fan WW Lai SS So WM Chan 2005 Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia: one-year results of a prospective series Eye 19 834 840
42. AP Ciardella IM Donsoff SJ Huang DL Costa LA Yannuzzi 2004 Polypoidal choroidal vasculopathy Surv Ophthalmol 49 25 37
43. CW Spraul HE Grossniklaus GK Lang 1997 Idiopathic polypoidal choroidal vasculopathy Klin Monatsbl Augenheilkd 210 405 406
44. M Quaranta M Mauget-Faysse G Coscas 2002 Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Am J Ophthalmol 134 277 280
45. AH Rogers PB Greenberg A Martidis CA Puliafito 2003 Photodynamic therapy of polypoidal choroidal vasculopathy Ophthalmic Surg Lasers Imaging 34 60 63
46. C Torron Fernandez-Blanco S Perez Olivan E Ferrer Novella O Ruiz-Moreno B Marcuello Melendo FM Honrubia Lopez 2003 Photodynamic therapy for choroidal neovascularization not caused by age-related macular degeneration or pathologic myopia Arch Soc Esp Oftalmol 78 471 476
47. SC Lee YS Seong SS Kim HJ Koh OW Kwon 2004 Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula Ophthalmologica 218 193 201
48. BA Lafaut AM Leys B Snyers 2000 Polypoidal choroidal vasculopathy in Caucasians Graefes Arch Clin Exp Ophthalmol 238 752 759
49. M Yuzawa R Mori M Haruyama 2003 A study of laser photocoagulation for polypoidal choroidal vasculopathy Jpn J Ophthalmol 47 379 384
50. AC Ho LA Yannuzzi K Pisicano J DeRosa 1995 The natural history of idiopathic subfoveal choroidal neovascularization Ophthalmology 102 782 789
51. B Lindblom T Andersson 1998 The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age Ophthalmology 105 1816 1820
52. M Sickenberg U Schmidt-Erfurth JW Miller 2000 A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes Arch Ophthalmol 118 327 336
53. RF Spaide ML Martin J Slakter 2002 Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin Am J Ophthalmol 134 62 68
54. AH Rogers JS Duker N Nichols BJ Baker 2003 Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization Ophthalmology 110 1315 1320
55. J Wachtlin A Wehner H Heimann MH Foerster 2004 Photodynamic treatment with verteporfin for patients with idiopathic choroidal neovascularization. Two-year results Ophthalmologe 101 489 495
56. WM Chan DS Lam TH Wong 2003 Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series Ophthalmology 110 2395 2402
57. JD Gass 1967 Pathogensis of disciform detachment of neuroepithelium: II. Idiopathic central serous chorioretinopathy Am J Ophthalmol 63 587 615
58. LS Hall DR Guyer LA Yannuzzi 1999 Central serous chorioretinopathy DR Guyer Retina-Vitreous-Macula WB Saunders Philadelphia 206 216
59. R Levine A Brucker F Robinson 1984 Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography Ophthalmology 91 1544 1548
60. RH Loo IU Scott HW Flynn Jr 2002 Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy Retina 22 19 24
61. F Cardillo Piccolino L Borgia 1994 Central serous chorioretinopathy and indocyanine green angiography Retina 14 231 242
62. DR Guyer LA Yannuzzi JS Slakter JA Sorenson A Ho D Orlok 1994 Digital indocyanine green angiography of central serous chorioretinopathy Arch Ophthalmol 112 1057 1062
63. C Prunte J Flammer 1996 Choroidal capillary and venous congestion in central serous chorioretinopathy Am J Ophthalmol 121 26 34
64. U Schmidt-Erfurth S Michels I Barbazetto H Laqua 2002 Photodynamic effects on choroidal neovascularization and physiological choroid Invest Ophthalmol Vis Sci 43 830 841
65. M Battaglia Parodi S Da Pozzo G Ravalico 2003 Photodynamic therapy in chronic central serous chorioretinopathy Retina 23 235 237
66. C Canakis C Livir-Rallatos Z Panayiotis 2003 Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy Am J Ophthalmol 136 750 752
67. F Cardillo Piccolino CM Eandi L Ventre RC Rigault de la Longrais FM Grignolo 2003 Photodynamic therapy for chronic central serous chorioretinopathy Retina 23 752 763
68. TY Lai WM Chan DS Lam 2004 Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy Am J Ophthalmol 137 826 833
69. E Rechtman RP Danis LM Pratt A Harris 2004 Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age-related macular degeneration Br J Ophthalmol 88 344 347
70. RF Spaide J Sorenson L Maranan 2003 Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization Ophthalmology 110 1517 1525
71. Eyetech Study Group 2003 Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results Ophthalmology 110 979 986